AstraZeneca targets $80bn revenue by 2030, ... AstraZeneca: Fascinating Company With Lofty Ambitions - Just Not A Buy Yet. Jun. 07, 2025 4:55 AM ET AstraZeneca PLC (AZN) ...

AstraZeneca is an established leader in respiratory care with a 50-year heritage and a growing portfolio of medicines in immune-mediated diseases. The company is committed to addressing the vast unmet ...

The Pittsburgh Paints Company (“Pittsburgh Paints Co.” or “the Company”) today unveiled the Company’s new logo and tagline, symbolizing the Company’s 150-yea ...

An Ohio company and a West Sacramento food vendor battling over a logo. An Ohio company and a West Sacramento food vendor battling over a logo. Skip to content. NOWCAST KCRA 3 News at 11pm.

Shares of AstraZeneca PLC (NASDAQ:AZN – Get Free Report) have been assigned an average recommendation of “Buy” from the ten brokerages that are currently covering the company, MarketBeat.com ...

Analysts at Morgan Stanley assumed coverage on shares of AstraZeneca (NASDAQ:AZN – Get Free Report) in a research note issued on Wednesday, Marketbeat.com reports. The firm set an “overweight ...

NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against ...

The logo of the British pharmaceutical company AstraZeneca is seen at the company's China Commercial Innovation Centre (CCIC) in Wuxi, Jiangsu province, China, September 15, 2018. Picture taken ...

LONDON — Pharmaceutical company AstraZeneca on Friday cancelled a planned 450 million-pound ($560 million) investment in a vaccine manufacturing plant in northwest England, blaming the new ...

LinkedIn likes have landed drugmakers in trouble once again. AstraZeneca—a repeat offender—and GSK were the subjects of the investigations under the U.K. | LinkedIn likes have landed ...

AstraZeneca's China president Leon Wang, who was detained last month by Chinese authorities, is in touch with a lawyer but the company has very little information about the case, its CEO said on ...

AstraZeneca has rolled out its latest campaign aimed at emphasizing its scientific achievements, dubbed “What science can do.” The campaign doesn’t market any particular product or therapeutic area, ...